Over the next quarter-century, the number of people living with type 1 diabetes is expected to grow from 9.4 million to 12.1 million worldwide — a rise shaped not only by biology and aging populations in wealthy nations, but by the slow, uneven spread of insulin access to places where survival itself has long been uncertain. Researchers at Steno Diabetes Center Odense have modeled this trajectory using historical patterns of care and population data, presenting their findings at the European Association for the Study of Diabetes meeting in Milan this autumn. The projection is, in one sense, a
Type 1 diabetes cases projected to surge 29% globally by 2049
Mortality among T1D patients projected to increase from 361,383 deaths in 2025 to 537,621 in 2049, with children aged 0-19 accounting for disproportionate mortality in low-income countries.